FDA Inspection 1232490 — Adventist HealthCare Shady Grove Medical Center
The FDA completed an inspection of Adventist HealthCare Shady Grove Medical Center on February 22, 2024 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 22, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville, MD (United States)